Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5455/JPMA.14 http://scihub22266oqcxt.onion/10.5455/JPMA.14 32515382!ä!32515382 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32515382.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Pak+Med+Assoc 2020 ; 70(Suppl 3) (5): S77-S80 Nephropedia Template TP {{tp|p=32515382|t=2020. Cardiovigilance in COVID 19 |pdf=|usr=}}{{32515382}} gab.com Text Cardiovigilance in COVID 19 JO: J Pak Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32515382 #FOAvip The COVID19 (Corona Virus Disease: pandemic started in 2019) pandemic has created not only a public health problem, but as a clinical challenge as well. To the cardiologist, COVID 19 presents a wide spectrum of possibilities for clinical decision-making intervention and improvement. Cardiac dysfunction has been identified as a risk factor, a prognostic factor, a diagnostic tool, differential diagnosis, a complication of COVID 19, and a side effect of its treatment. Certain cardiotropic drugs have been implicated in the pathogenesis of COVID 19. The risk of transmission of COVID 19 is an occupational hazard which cannot be ignored by cardiologists. This review discusses the need and scope of cardio vigilance in COVID 19 management. Twit Text FOAVip Cardiovigilance in COVID 19 ????J Pak Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32515382 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32515382 #FOAvip English Wikipedia <ref>{{Cite pmid|32515382}}</ref> Cardiovigilance in COVID 19 #MMPMID32515382 Kishor K; Marwah R; Anantharaj A; Kalra S J Pak Med Assoc 2020[May]; 70(Suppl 3) (5): S77-S80 PMID32515382show ga The COVID19 (Corona Virus Disease: pandemic started in 2019) pandemic has created not only a public health problem, but as a clinical challenge as well. To the cardiologist, COVID 19 presents a wide spectrum of possibilities for clinical decision-making intervention and improvement. Cardiac dysfunction has been identified as a risk factor, a prognostic factor, a diagnostic tool, differential diagnosis, a complication of COVID 19, and a side effect of its treatment. Certain cardiotropic drugs have been implicated in the pathogenesis of COVID 19. The risk of transmission of COVID 19 is an occupational hazard which cannot be ignored by cardiologists. This review discusses the need and scope of cardio vigilance in COVID 19 management. |*Betacoronavirus[MESH] |*Coronavirus Infections/complications/diagnosis/epidemiology[MESH] |*Heart Diseases/complications/drug therapy/epidemiology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications/diagnosis/epidemiology[MESH] |COVID-19[MESH] |Clinical Decision-Making[MESH] |Humans[MESH] |Risk Factors[MESH]Cardiovigilance in COVID 19 (epmc).pdf DeepDyve Pubget Overpricing